2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Breast Neoplasms
33
Colorectal Neoplasms
13
Neoplasms
11
Pain, Postoperative
10
Lung Neoplasms
9
Brain Neoplasms
8
Stomach Neoplasms
7
Prostatic Neoplasms
7
Pancreatic Neoplasms
7
Carcinoma, Non-Small-Cell Lung
7
Melanoma
6
Leukemia, Myeloid, Acute
5
Ovarian Neoplasms
4
Myoma
4
Lymphoma, Non-Hodgkin
4
Leiomyoma
4
Hemorrhage
4
Head and Neck Neoplasms
4
Glioblastoma
4
Colonic Neoplasms
4
Agnosia
4
Skin Neoplasms
3
Recurrence
3
Rectal Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Neurotoxicity Syndromes
3
Neoplasm Metastasis
3
Nasopharyngeal Carcinoma
3
Myelodysplastic Syndromes
3
Multiple Endocrine Neoplasia Type 1
3
Interventions
Parathyroidectomy
5
Cinacalcet
3
fluorocholine
2
belinostat
2
Trastuzumab
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Denosumab
2
tumor necrosis factor-alpha, CNGRC fusion protein, human
1
tipifarnib
1
lutetium Lu 177 dotatate
1
gallium Ga 68 dotatate
1
fluorodopa F 18
1
evocalcet
1
entinostat
1
acetaminophen, codeine drug combination
1
Tramadol
1
Tablets
1
Standard of Care
1
Specimen Handling
1
Sodium Chloride
1
Rubidium-82
1
Ritonavir
1
Radiotherapy
1
Quality of Life
1
Patient Reported Outcome Measures
1
Molecular Diagnostic Techniques
1
Ipilimumab
1
Interleukin-12 Subunit p35
1
Interleukin-12
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Parathyroid Neoplasms
×
Sodium Chloride
×
Clear all
NCT03027557
2021-05-25
DENOCINA
Aalborg University Hospital
Phase 3
Completed
46 enrolled
49 charts